Dia 2 Portuguese Subtitles DISLIPIDEMIAS GRAVES NA AMÉRICA LATINA: ENFRENTANDO O FUTURO – IASEC

Skip to content

EDUCATION CENTER HOME
LEARNING LIBRARY TOPICS

Home
Dia 2 Portuguese Subtitles DISLIPIDEMIAS GRAVES NA AMÉRICA LATINA: ENFRENTANDO O FUTURO

Current Status

Not Enrolled

Price

Free

Get Started

Login to Enroll

DISLIPIDEMIAS GRAVES NA AMÉRICA LATINA: ENFRENTANDO O FUTURO

Dia 2 - HIPERCOLESTEROLEMIAS GRAVES

Dia 2 Co-presidentes

Maria Cristina Izar (Brasil)

Juan Patricio Nogueira (Argentina)

Course Content

Fórum 3

Genética da hipercolesterolemia com foco nas formas monogênicas – Robert Hegele (Canadá)

História natural da HF homozigótica e sua epidemiologia na América Latina – Rodrigo Alonso (Chile)

Definindo o fenótipo de HF grave e suas implicações – Raul Santos (Brasil)

Fórum de discussão 3 – Painelista Pablo Corral (Argentina)

Co-presidente resumo das palestras e principais mensagens – Juan Patricio Nogueira (Argentina)

Fórum 4

Hipercolesterolemia pediátrica grave – Samuel Gidding (EUA)

Inibidores de PCSK9 em HF grave – Maria Cristina Izar (Brasil)

Eficácia e segurança do lomitapide na HF homozigótica – Dirk Blom (África do Sul)

Novas terapias para HF grave – Paola Varleta (Chile)

Fórum de discussão 4 Painelista – Roopa Mehta (México)

Co-presidente resumo das palestras e principais mensagens – Maria Cristina Izar (Brasil)

Dia 2 Pós-teste

Course Content

Fórum 3

Genética da hipercolesterolemia com foco nas formas monogênicas – Robert Hegele (Canadá)

História natural da HF homozigótica e sua epidemiologia na América Latina – Rodrigo Alonso (Chile)

Definindo o fenótipo de HF grave e suas implicações – Raul Santos (Brasil)

Fórum de discussão 3 – Painelista Pablo Corral (Argentina)

Co-presidente resumo das palestras e principais mensagens – Juan Patricio Nogueira (Argentina)

Fórum 4

Hipercolesterolemia pediátrica grave – Samuel Gidding (EUA)

Inibidores de PCSK9 em HF grave – Maria Cristina Izar (Brasil)

Eficácia e segurança do lomitapide na HF homozigótica – Dirk Blom (África do Sul)

Novas terapias para HF grave – Paola Varleta (Chile)

Fórum de discussão 4 Painelista – Roopa Mehta (México)

Co-presidente resumo das palestras e principais mensagens – Maria Cristina Izar (Brasil)

Dia 2 Pós-teste

The content on this site is intended for healthcare professionals only.
Financial Support-The IAS maintains its independence and has not received funding specific to the development and release of the IAS Education Center. Programs and materials contained within this site have been accessed through multiple resources for presentation and may or may not have received sponsorship or other forms of support to enable presentation. If received, all such support shall be disclosed in the presentation of each activity.
Regarding medical related content: The IAS is a global non-profit medical organization that seeks to address health-related issues related to atherosclerosis and related disease. The information presented in this site is for informational and educational purposes only and not a substitute for professional medical advice, diagnosis or treatment by a qualified medical professional. If you are a patient in need of care or considering care, call your doctor for appropriate medical evaluation and advice. If you think you may have a medical emergency, please dial your local emergency response phone number.
© 2020 IAS. All rights reserved.
Terms of Service
Privacy Policy
Cookie Policy